Akari Therapeutics

NASDAQ: AKTX · Real-Time Price · USD
1.00
0.03 (3.08%)
At close: Aug 15, 2025, 3:58 PM
1.00
0.00%
After-hours: Aug 15, 2025, 04:10 PM EDT

Akari Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-17.93M -19.79M -16.02M -13.13M -8.57M -2.01M -2.01M -2.01M -4.69M -10.86M -16.65M -18.1M -16.76M -17.42M -18.46M -15.56M -19.54M
Depreciation & Amortization
1K 14K 13K 13K 14.85K 2.85K 2.85K 2.85K 1.94K 1.95K 2.96K 3.99K 4.1K 4.13K 4.12K 4.07K 6.06K
Stock-Based Compensation
3.26M 2.25M 989.3K 1.35K 1.18K 1.14K 1.1K 1.05K 123.63K 222.21K 298.99K 369.35K 328.59K 314.65K 318.19K 328.68K 309.91K
Other Working Capital
-55K 1.54M 534.00 1.6M 1.1M -1.06M -1.06M -1.06M -3.52M -2.85M -1.95M -2.13M 298.12K -1.74M -2.64M -2.46M -1.93M
Other Non-Cash Items
3.5M 3.46M 4.61M 2.6M -3.12M -8.38M -8.38M -8.38M -5.38M -142.41K -90.25K -88.62K -105.34K 242.5K 43.61K -1.76M 1.6M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
512K 1.54M 534.00 1.6M 680.44K -1.48M -1.48M -1.48M -3.52M -2.85M -2.2M -2.37M 56.81K -1.98M 16.37K -224.46K 990.66K
Operating Cash Flow
-10.66M -12.55M -10.43M -8.94M -13.62M -14.46M -14.46M -14.46M -13.46M -13.63M -18.63M -20.19M -16.48M -18.85M -18.08M -17.22M -16.63M
Capital Expenditures
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
n/a n/a n/a n/a n/a n/a -0.16 -10.7K -10.7K -10.7K -10.7K n/a n/a n/a n/a n/a n/a
Debt Repayment
-1.15M -640K 333K 669K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
1.12M -187K -184.24K -208.48K 3M 6.43M 12.88M 19.34M 16.13M 12.92M 6.46M n/a n/a n/a n/a n/a 27.5K
Financial Cash Flow
11.61M 10.99M 8.84M 9.28M 5.02M 6.72M 6.72M 6.72M 3.22M 12.38M 13.49M 24.67M 26.66M 14.29M 19.17M 7.99M 15.2M
Net Cash Flow
1.33M 2.66M 574.28K 837.41K 5.14M -4.31M -88.82K 9.71M -6.03M 9.47M 2.9M 4.36M 10.05M -4.69M 1.07M -8.95M -1.15M
Free Cash Flow
-10.66M -12.55M -10.43M -8.94M -13.62M -14.46M -14.46M -14.46M -13.46M -13.63M -18.63M -20.19M -16.48M -18.85M -18.08M -17.22M -16.63M